🇺🇸 FDA
Patent

US 12202841

Therapeutic agents for enhancing epithelial and/or endothelial barrier function

granted A61KA61K31/055A61K31/352

Quick answer

US patent 12202841 (Therapeutic agents for enhancing epithelial and/or endothelial barrier function) held by INSTITUTE FOR STEM CELL SCIENCE AND REGENERATIVE MEDICINE expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INSTITUTE FOR STEM CELL SCIENCE AND REGENERATIVE MEDICINE
Grant date
Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/055, A61K31/352, A61K31/519, A61K9/0053